MCOLN2 and glioblastoma: The low TRPML2 expression was significantly correlated with the higher survival time of GBM patients, whereas negative and high-expressing GBM patients were associated with a reduction of OS compared to low-TRPML2-expressing GBM patients (Figure 1A–C).